Chemical strategies for development of ATR inhibitors
Authors:
- 9 May 2014
- journal article
- review article
- Published by Cambridge University Press (CUP) in Expert Reviews in Molecular Medicine
- Vol. 16, e10
Abstract
ATR protein kinase is one of the key players in maintaining genome integrity and coordinating of the DNA damage response and repair signalling pathways. Inhibition of ATR prevents signalling from stalled replication forks and enhances the formation of DNA damage, particularly under conditions of replication stress present in cancers. For this reason ATR/CHK1 checkpoint inhibitors can potentiate the effect of DNA cross-linking agents, as evidenced by ATR inhibitors recently entering human clinical trials. This review aims to compile the existing literature on small molecule inhibitors of ATR, both from academia and the pharmaceutical industry, and will provide the reader with a comprehensive summary of this promising oncology target.Keywords
This publication has 47 references indexed in Scilit:
- Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell linesBritish Journal of Cancer, 2011
- RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastomaProceedings of the National Academy of Sciences, 2011
- The ATR barrier to replication-born DNA damageDNA Repair, 2010
- Targeting the cancer kinome through polypharmacologyNature Reviews Cancer, 2010
- Inhibition of ATR protein kinase activity by schisandrin B in DNA damage responseNucleic Acids Research, 2009
- TopBP1 activates ATR through ATRIP and a PIKK regulatory domainGenes & Development, 2008
- ATR signaling can drive cells into senescence in the absence of DNA breaksGenes & Development, 2008
- The Rad9–Hus1–Rad1 (9–1–1) clamp activates checkpoint signaling via TopBP1Genes & Development, 2007
- Phosphorylation of FANCD2 on Two Novel Sites Is Required for Mitomycin C ResistanceMolecular and Cellular Biology, 2006
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingCell, 2006